IS THIS THE BEST BIOTECH GROWTH STOCK?
I've held Editas Medicine as one of my top holdings for a couple of years now, this 𝗣𝗔𝗧𝗜𝗘𝗡𝗖𝗘 seems to be paying off with the stock rising 200% this month!
I have been expecting this surge for a long time and I think this could just be the start! 𝗦𝗢 what is causing this rise 𝗔𝗡𝗗 how high can Editas go!
WHAT THE HELL IS EDITAS MEDICINE?
Editas is a biotech company that specialises in genome editing.
OKAY... WHAT IS GENOME EDITING?
Genome editing is a method that lets scientists change the DNA of plants, animals and humans. Although plants, animals… and humans have been selectively bred for decades, scientists have advanced this process by learning how to genetically modify the 𝗗𝗡𝗔 of plants to produce foods with less fats, gluten and greater resistance to bacteria!
Now we know that manipulating the DNA of plants doesn’t result in flesh eating zombie pineapples, scientists are beginning to explore the use of genome editing in humans! Early-stage trials are underway to see how effective gene-editing and more specifically 𝗖𝗥𝗜𝗦𝗣𝗥 (a new gene editing tool) is at treating numerous diseases from cancer to blindness!
The global genome editing market is expected to triple in size over the next 5 years. However these estimates should be considered conservative given how the current pandemic has highlighted our need to better understand immunology and gene-editing is at the 𝗖𝗨𝗧𝗧𝗜𝗡𝗚 𝗘𝗗𝗚𝗘 of this industry!
WHY IS EDITAS MEDICINE STOCK RISING?
Editas is not the only gene-editing company doing extremely well this year! The entire sector is getting a 𝗕𝗢𝗢𝗦𝗧 for a number of reasons including:
⚡ This year scientists used gene-editing technology to create successful cancer fighting cells for the first time.
⚡ Vertex Pharmaceuticals provided very positive data on their CRISPR based therapy to treat beta thalassemia
⚡ CRISPR is now being commonly used to engineer mice and accelerate vaccine development
⚡ Breakthroughs have been made using CRISPR to improve the cultivation of rice to tackle world hunger
⚡ Last week, the CEO of Ark Invest - Cathie Wood said that she expects the biggest upside surprises are going to come from the genomic space
𝗧𝗛𝗔𝗧 𝗦𝗔𝗜𝗗, Editas Medicine has delivered some exciting news of it’s own…
⚡ The company submitted a request with FDA to begin a phase 1/2 study of EDIT-301 in treating sickle cell disease
⚡ Editas is evaluating the use of another pipeline candidate (Edit-101) to treat a leading cause of blindness
⚡ The company not only holds the most patents in the gene-editing industry but they recently extended their partnerships with MIT & Harvard which will give Editas exclusive rights to Crispr technologies developed by these 2 prestigious schools until 2024.
⚡ Oh and revenue grew over 400% this year!
All of the above is great news for Editas medicine! However, more importantly the progression of CRISPR & gene-editing could be huge for humanity! If data from upcoming clinical studies is as positive as the findings from 𝗣𝗥𝗘-clinical studies – CRISPR has the potential to help millions of people through agricultural advancements and the treatment of disease.
Therefore, the total 𝗔𝗗𝗗𝗥𝗘𝗦𝗦𝗔𝗕𝗟𝗘 𝗠𝗔𝗥𝗞𝗘𝗧 𝗦𝗜𝗭𝗘 for gene-editing companies is beginning to look enormous. Successful companies in this sector will see huge share price appreciation and Editas is more likely than any to succeed thanks to their early mover advantage, patents and exclusive partnerships with some of the world’s greatest universities!
HOW HIGH CAN EDITAS GO?
I posted this comment 7 months ago:
“𝐼'𝑚 𝑎𝑏𝑜𝑢𝑡 𝑡𝑜 𝑑𝑜 𝑎𝑛 𝐴𝑅𝐾 𝑖𝑛𝑣𝑒𝑠𝑡𝑚𝑒𝑛𝑡 𝑠𝑡𝑦𝑙𝑒 $𝑇𝑆𝐿𝐴 𝑝𝑟𝑖𝑐𝑒 𝑡𝑎𝑟𝑔𝑒𝑡 ℎ𝑒𝑟𝑒 𝑎𝑛𝑑 𝑝𝑟𝑒𝑑𝑖𝑐𝑡 𝑡ℎ𝑎𝑡 𝐸𝑑𝑖𝑡𝑎𝑠 𝑀𝑒𝑑𝑖𝑐𝑖𝑛𝑒 𝑤𝑖𝑙𝑙 𝑟𝑒𝑎𝑐ℎ $75 𝑝𝑒𝑟 𝑠ℎ𝑎𝑟𝑒 (+300%) 𝑖𝑛 2021!”
I am still yet to trim my position in the stock despite Editas currently trading above $80. I believe it will be a volatile ride, however I would not be surprised if Editas Medicine one day commanded a market cap of 𝟰𝟬-𝟴𝟬𝗯𝗻… Up alongside the likes of Illumina.
The stock is flying and therefore could be due a pullback, long term though Editas Medicine is a 𝗛𝗨𝗚𝗘 𝗕𝗨𝗬!
Make sure to check out these popular blog posts!
#tradeinplaces #trading #trade #learntotrade #learntoinvest #etoro #finance #financialfreedom #investing #travelblog #travelling #stocks #stockmarket #stockstowatch #investor #investment #howtoinvest #howtotrade #marketcap #ipo #movingaverage #correction #volume #pricetarget #beta #dividend #leverage #spread #stocksplit #blockchain #cryptocurrency #alibaba #jd.com #ecommerce #bilibili #pinduoduo #bitcoin #ethereum #eth #2020 #2021